(Q41742297)

English

Risk factor modification: rationale for management of dyslipidemia

scientific article published on February 1998

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

8 October 2017

1 reference

Europe PubMed Central

title

Risk factor modification: rationale for management of dyslipidemia (English)

1 reference

stated in

Europe PubMed Central

8 October 2017

1 reference

A M Gotto

1

1 reference

stated in

Europe PubMed Central

PubMed ID

9550500

retrieved

8 October 2017

language of work or name

English

0 references

publication date

1 February 1998

1 reference

stated in

Europe PubMed Central

8 October 2017

American Journal of Medicine

1 reference

stated in

Europe PubMed Central

8 October 2017

104

1 reference

stated in

Europe PubMed Central

8 October 2017

2A

1 reference

stated in

Europe PubMed Central

8 October 2017

6S-8S

1 reference

stated in

Europe PubMed Central

8 October 2017

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900039-4

retrieved

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900039-4

retrieved

7 January 2021

Lipid-lowering interventions in angiographic trials

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900039-4

retrieved

7 January 2021

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900039-4

retrieved

7 January 2021

Drug therapy for hypercholesterolemia in patients with cardiovascular disease: factors limiting achievement of lipid goals

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900039-4

retrieved

7 January 2021

Identifiers

DOI

10.1016/S0002-9343(98)00039-4

1 reference

stated in

Europe PubMed Central

8 October 2017

1 reference

Europe PubMed Central

PubMed ID

9550500

retrieved

8 October 2017

(Q41742297)

Risk factor modification: rationale for management of dyslipidemia

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)